Financhill
Back

Verrica Pharmaceuticals Stock Predictions

Verrica Pharmaceuticals Stock Forecast

  • Is Verrica Pharmaceuticals Stock Undervalued?
    The current Verrica Pharmaceuticals [VRCA] share price is $0.99. The Score for VRCA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • VRCA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Verrica Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Verrica Pharmaceuticals Stock Rating

Data Unavailable

Verrica Pharmaceuticals Stock Price History

Is VRCA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
verrica.com

52-Week Data

52-Week High:
11.41
52-Week Low:
0.70

Prediction Charts

Market Cap:
45.35M
Price in USD:
0.99
Volume:
552.64K
Beta:
1.94

Technical Analysis

SMA50:
1.36
SMA100:
3.19
SMA200:
5.01
52-Wk Change:
-72.75%

Stock Predictions

  • Is Verrica Pharmaceuticals stock public?
    Yes, Verrica Pharmaceuticals is a publicly traded company.
  • What is the Verrica Pharmaceuticals stock quote today?
    The Verrica Pharmaceuticals stock price is 0.99 USD today.
  • How to buy Verrica Pharmaceuticals stock online?
    You can buy Verrica Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 0.93 0.80 0.94 0.75
Nov-6 0.84 0.75 0.87 0.74
Nov-7 0.75 0.70 0.77 0.70
Nov-8 0.72 0.83 0.83 0.71
Nov-11 0.83 0.96 0.98 0.83
Nov-12 0.99 0.93 1.00 0.87
Nov-13 0.91 0.84 0.93 0.83
Nov-14 0.86 0.86 0.94 0.83
Nov-15 0.87 0.83 0.89 0.79
Nov-18 0.84 0.89 0.89 0.81
Nov-19 0.88 0.89 0.89 0.80
Nov-20 0.89 0.89 0.92 0.85
Nov-21 0.90 0.99 1.09 0.85
Nov-22 0.98 0.99 1.02 0.96

Verrica Pharmaceuticals Earnings

Data Unavailable

Verrica Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.

* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.